Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.

In the present study the release mechanism of the sparingly water-soluble drug felodipine (FELO) from particulate solid dispersions in PVP or PEG was investigated. FT-IR data indicated that a N-H...O hydrogen bond is formed between FELO and polymers. The drug-polymer interaction was theoretically studied with the density functional theory with the B3LYP exchange correlation function. The interaction energies have been estimated at -31.8 kJ/mol for PVP and -18.8 kJ/mol for PEG. Also, detailed vibrational analysis of the complexes showed that the red shift of the N-H bond stretching in FELO molecule due to H-bonding was higher in the FELO-PVP complex than in the FELO-PEG complex. Both the experimental and theoretical data indicated that a stronger interaction of FELO with PVP than with PEG was developed. The interactions of FELO with the polymer appeared to control the physical state (amorphous or crystalline) and the particle size of FELO in the solid dispersions. In the FELO/PVP dispersions, the drug is found as amorphous nanoparticles whereas in FELO/PEG dispersions the drug is dispersed as crystalline microparticles. The size of drug particles in the dispersion was also influenced by drug proportion, with an increase in drug content of the dispersion resulting in increased drug particle size. The particle size of drug, the proportion of drug in the dispersion and the properties of the polymer (molecular weight) appeared to determine the mechanism of drug release from the solid dispersions, which was drug diffusion (through the polymer layer)-controlled at low drug contents and drug dissolution-controlled at high drug contents. In situ DLS measurements indicate that the large initial particles of FELO/PVP and FELO/PEG solid dispersions with low drug content (10-20 wt%) are very rapidly decreased to smaller particles (including nanoparticles) during dissolution, leading to the observed impressive enhancement of FELO release rate from these dispersions.

[1]  Jeong-Sook Park,et al.  Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process. , 2005, International journal of pharmaceutics.

[2]  L. Gargallo,et al.  Unperturbed dimensions of polyvinylpyrrolidone in pure solvents and in binary mixtures , 1977 .

[3]  O. Corrigan Mechanisms of Dissolution of Fast Release Solid Dispersions , 1985 .

[4]  C. Nyström,et al.  Physicochemical aspects of drug release: X. Investigation of the applicability of the cube root law for characterization of the dissolution rate of fine particulate materials , 1990 .

[5]  L. Adamowicz,et al.  IR spectral and theoretical characterization of intramolecular hydrogen bonds closing five-membered rings , 2001 .

[6]  E. Pavlidou,et al.  Physicochemical studies on solid dispersions of poorly water-soluble drugs: Evaluation of capabilities and limitations of thermal analysis techniques , 2005 .

[7]  Experimental and theoretical studies of malonaldehyde: vibrational analysis of a strongly intramolecularly hydrogen bonded compound , 1992 .

[8]  Jm Newton,et al.  THE DISSOLUTION OF NORTRIPTYLINE HCL FROM POLYETHYLENE-GLYCOL SOLID DISPERSIONS , 1992 .

[9]  S. Riegelman,et al.  Pharmaceutical applications of solid dispersion systems. , 1971, Journal of pharmaceutical sciences.

[10]  W. Stockmayer Problems of the statistical thermodynamics of dilute polymer solutions , 1960 .

[11]  A. Serajuddin,et al.  Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. , 1999, Journal of pharmaceutical sciences.

[12]  N. Peppas,et al.  Drug/Polymer Matrix Swelling and Dissolution , 2004, Pharmaceutical Research.

[13]  I. Pajeva,et al.  Interactions of Poly(vinylpyrrolidone) with Ibuprofen and Naproxen: Experimental and Modeling Studies , 2005, Pharmaceutical Research.

[14]  Dimitrios N. Bikiaris,et al.  Hydrophilic matrices as carriers in felodipine solid dispersion systems , 2001 .

[15]  D. L. Munday,et al.  Relationship between swelling, erosion and drug release in hydrophillic natural gum mini-matrix formulations. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[16]  Ž. Knez,et al.  Micronization of drugs using supercritical carbon dioxide. , 1999, International journal of pharmaceutics.

[17]  D. Craig,et al.  An investigation into the mechanisms of dissolution of alkyl p-aminobenzoates from polyethylene glycol solid dispersions , 1992 .

[18]  Evangelos Karavas,et al.  Miscibility Behavior and Formation Mechanism of Stabilized Felodipine-Polyvinylpyrrolidone Amorphous Solid Dispersions , 2005, Drug development and industrial pharmacy.

[19]  Aditya Mohan Kaushal,et al.  Amorphous drug delivery systems: molecular aspects, design, and performance. , 2004, Critical reviews in therapeutic drug carrier systems.

[20]  A. Xenakis,et al.  Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[21]  J. Newton,et al.  Assessment of the wettability of powders by use of compressed powder discs , 1986 .

[22]  W. L. Chiou,et al.  PHARMACEUTICAL APPLICATIONS OF SOLID DISPERSIONS , 1971 .

[23]  Y. Marcus,et al.  An empirical correlation between stretching vibration redshift and hydrogen bond length , 2000 .

[24]  J. Dressman,et al.  Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. , 1997, Advanced drug delivery reviews.

[25]  R. Bodmeier,et al.  Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[26]  S. Clas,et al.  Crystallization inhibition in solid dispersions of MK-0591 and poly(vinylpyrrolidone) polymers. , 2000, Journal of pharmaceutical sciences.

[27]  J. B. Park,et al.  Characteristics of felodipine-located poly(ε-caprolactone) microspheres , 2005 .

[28]  D. Craig,et al.  The mechanisms of drug release from solid dispersions in water-soluble polymers. , 2002, International journal of pharmaceutics.

[29]  A. Bansal,et al.  Role of molecular interaction in stability of celecoxib-PVP amorphous systems. , 2005, Molecular pharmaceutics.

[30]  C. Nyström,et al.  Physicochemical aspects of drug release. VI. Drug dissolution rate from solid particulate dispersions and the importance of carrier and drug particle properties , 1988 .

[31]  D. Bikiaris,et al.  Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[32]  A. Bansal,et al.  Devitrification of amorphous celecoxib , 2005, AAPS PharmSciTech.

[33]  B. Abrahamsson,et al.  Evaluation of Solubilizers in the Drug Release Testing of Hydrophilic Matrix Extended-Release Tablets of Felodipine , 1994, Pharmaceutical Research.

[34]  D. Bikiaris,et al.  Felodipine nanodispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer. , 2006, International journal of pharmaceutics.